Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
- DOI
- 10.1186/s13063-021-05363-w
- Published
- 2021-07-06
- Container
- Trials
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13063-021-05363-w,
title = {Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial},
author = {Hamid Reza Samimagham and Mehdi Hassani Azad and Dariush Hooshyar and Maryam Haddad and Mohsen Arabi and Mitra KazemiJahromi},
year = {2021},
journal = {Trials},
doi = {10.1186/s13063-021-05363-w},
url = {https://doi.org/10.1186/s13063-021-05363-w}
}RIS
TY - JOUR TI - Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial AU - Hamid Reza Samimagham AU - Mehdi Hassani Azad AU - Dariush Hooshyar AU - Maryam Haddad AU - Mohsen Arabi AU - Mitra KazemiJahromi PY - 2021 JO - Trials DO - 10.1186/s13063-021-05363-w UR - https://doi.org/10.1186/s13063-021-05363-w ER -
APA
Samimagham, H. R., Azad, M. H., Hooshyar, D., Haddad, M., Arabi, M., & KazemiJahromi, M. (2021). Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial. Trials. https://doi.org/10.1186/s13063-021-05363-w
Source records
- crossref · retrieved 2026-09-25T19:14:14.594Z